Sanofi Nears €15.5 Billion Sale of 50% Stake in Opella to CD&R

Oct 11, 2024, 04:44 AM

Sanofi is nearing a significant deal to sell a 50% controlling stake in its consumer health unit, Opella, to Clayton Dubilier & Rice (CD&R). The transaction, valued at approximately €15.5 billion ($16 billion), is poised to be one of the largest deals of the year. CD&R has reportedly outbid rivals, including a consortium led by PAI Partners, to secure this acquisition. The sale, estimated at €15 billion, is seen as a critical health check for mega leveraged buyouts (LBOs) and underscores the growing interest in the consumer health sector.